References
Crane J, Pearce N, Burgess C, et al. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol 1992 Aug; 21(4): 737–44
Joseph KS, Blais L, Ernst P, et al. Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillizers. BMJ 1996 Jan 13; 312(7023): 79–82
Joseph KS. Asthma mortality and antipsychotic or sedative use. What is the link? Drug Saf 1997 Jun; 16(6): 351–4
Sonin L, Patterson R. Corticosteroid-dependent asthma and schizophrenia. Arch Intern Med 1984 Mar; 144(3): 554–6
Giovino GA, Henningfield JE, Tomar SL, et al. Epidemiology of tobacco use and dependence. Epidemiol Rev 1995; 17(1): 48–65
Szefler SJ, Toogood JH, Spector SL, et al. Corticosteroids. J Allergy Clin Immunol 1987 Sep; 80(3 Pt 2): 441–2
British Thoracic Association. Death from asthma in two regions of England. BMJ 1982 Oct 30; 285(6350): 1251–5
Mohan G, Harrison BDW, Badminton RM, et al. A confidential enquiry into deaths caused by asthma in an English health region; implications for general practice. Br J Gen Pract 1996 Sep; 46(410): 529–32
Alt HL. Psychiatric aspects of asthma. Chest 1992 Jun; 101(6) Suppl.: 415S–7S
Siegel SC. History of asthma deaths from antiquity. J Allergy Clin Immunol 1987 Sep; 80(3 Pt 2): 458–62
Bennet DR, Dickinson BD, editors. Drug evaluations annual 1994. Chicago (IL): American Medical Association, 1994: 261–85
Rights and permissions
About this article
Cite this article
Antipsychotics and sedatives may increase the risk of asthma mortality. Drugs Ther. Perspect 10, 10–12 (1997). https://doi.org/10.2165/00042310-199710080-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199710080-00004